Bettina E Hansen

Bettina E Hansen

University of Toronto

H-index: 91

North America-Canada

About Bettina E Hansen

Bettina E Hansen, With an exceptional h-index of 91 and a recent h-index of 61 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of Biostatistics liver disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Single-cell and spatial transcriptomics characterisation of the immunological landscape in the healthy and PSC human liver

CANADIAN

Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated …

Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario

Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study

Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

A296 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AND PRIMARY SCLEROSING CHOLANGITIS: A RETROSPECTIVE STUDY OF A HIGH-VOLUME PROGRAMME

Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada

Bettina E Hansen Information

University

Position

Associate Professor

Citations(all)

34113

Citations(since 2020)

14293

Cited By

25229

hIndex(all)

91

hIndex(since 2020)

61

i10Index(all)

316

i10Index(since 2020)

233

Email

University Profile Page

Google Scholar

Bettina E Hansen Skills & Research Interests

Biostatistics liver disease

Top articles of Bettina E Hansen

Single-cell and spatial transcriptomics characterisation of the immunological landscape in the healthy and PSC human liver

Journal of Hepatology

2024/1/8

CANADIAN

2023

Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario

Journal of Obstetrics and Gynaecology Canada

2024/6/1

Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study

Journal of Hepatology

2024/3/24

Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

Hepatology

2024/3/22

A296 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AND PRIMARY SCLEROSING CHOLANGITIS: A RETROSPECTIVE STUDY OF A HIGH-VOLUME PROGRAMME

Journal of the Canadian Association of Gastroenterology

2024/3/1

Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada

Journal of Viral Hepatitis

2024/2/22

Characterizing the burden of biliary tract cancers across 28 hospitals in Ontario, Canada

Cancer

2024/2/15

Factors associated with knowledge and awareness of Hepatitis B in individuals of Chinese descent: Results from a mass point of care testing and outreach campaign in Toronto, Canada

Canadian Liver Journal

2024/2/2

Bettina E Hansen
Bettina E Hansen

H-Index: 55

Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large …

Digestive and Liver Disease

2024/2/1

Autoimmune hepatitis cholestatic variant syndromes recurrence following liver transplantation affects graft and patient survival in an international multicentre cohort

Digestive and Liver Disease

2024/2/1

Predictors of early and long-term readmissions and their association with survival after liver transplantation

Journal of Liver Transplantation

2024/2/1

Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe

Journal of Hepatology

2024/2/1

Bettina E Hansen
Bettina E Hansen

H-Index: 55

Addition of PEG‐interferon to long‐term nucleos (t) ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B: Multicentre Randomized …

Journal of Viral Hepatitis

2024/1/19

Levels of antibodies to hepatitis B core antigen are associated with liver inflammation and response to peginterferon in patients with chronic hepatitis B

The Journal of Infectious Diseases

2023/1/1

Bettina E Hansen
Bettina E Hansen

H-Index: 55

Controlled human infection model for hepatitis C virus vaccine development: trial design considerations

Clinical Infectious Diseases

2023/8/15

Pancreatic Cyst Follow-up, an International Collaboration PACYFIC study

2023/3/20

Bettina E Hansen
Bettina E Hansen

H-Index: 55

Julia Mayerle
Julia Mayerle

H-Index: 54

Analysis of Time to Treatment and Survival Among Adults Younger Than 50 Years of Age With Colorectal Cancer in Canada

JAMA Network Open

2023/8/1

Bettina E Hansen
Bettina E Hansen

H-Index: 55

See List of Professors in Bettina E Hansen University(University of Toronto)